Dadun/></a>
				</td>
				<td class= Dadun
   (New user)
Help  | Contact  |  Castellano English  
 

Dadun > Depósito Académico > Clínica Universidad de Navarra > Hepatología > DA - CUN - Hepatología - Artículos de revista >

De novo malignancies following liver transplantation: impact and recommendations
Authors: Herrero, J.I. (José Ignacio)
Keywords: Liver transplantation/adverse effects
Neoplasms/chemically induced/epidemiology/etiology
Postoperative complications/mortality
Issue Date: 2009
Publisher: Wiley-Blackwell
Publisher version: http://onlinelibrary.wiley.com/doi/10.1002/lt.21898/pdf
ISSN: 1527-6465
Citation: Herrero JI. De novo malignancies following liver transplantation: impact and recommendations. Liver Transpl 2009 Nov;15 Suppl 2:S90-4.
Abstract
1. De novo malignancy is one of the leading causes of late mortality after liver transplantation. 2. The risks of skin cancers and lymphoma are more than 10-fold greater than the risks in an age-matched and sex-matched general population. 3. Some types of neoplasia, such as lung, head and neck, and colorectal cancer, are more frequent in liver transplant recipients than in an age-matched and sexmatched population. The risks of other frequent malignancies, such as prostate and breast cancer, do not seem to be increased. 4. The most important risks for posttransplant malignancy are Epstein-Barr virus seronegativity (for lymphoma), sun exposure (for skin cancer), smoking, and increasing age. 5. Despite the absence of evidence, general recommendations (such as avoidance of overimmunosuppression, sunlight protection, and cessation of smoking) should be given. Screening protocols may help to detect neoplasia at an early stage of disease.
Permanent link: http://hdl.handle.net/10171/22544
Appears in Collections:DA - CUN - Hepatología - Artículos de revista

Files in This Item:
File:  Liver Transpl 2009. s90.pdf
Description: 
Size:  178,34 kB
Format:  Adobe PDF
 View / Open 

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.